Higuchi, Ryota

Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)

Kiriyama, S., Kozaka, K., Takada, T., Strasberg, S. M., Pitt, H. A., Gabata, T., Hata, J., Liau, K., Miura, F., Horiguchi, A., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersSepsis Diagnosis and Treatment

Cited by 761

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis

Gomi, H., Solomkin, J. S., Schlossberg, D., Okamoto, K., Takada, T., Strasberg, S. M., Ukai, T., Endo, I., Iwashita, Y., Hibi, T., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersAntibiotic Use and Resistance

Cited by 451

Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis

Mayumi, T., Okamoto, K., Takada, T., Strasberg, S. M., Solomkin, J. S., Schlossberg, D., Pitt, H. A., Yoshida, M., Gomi, H., Miura, F., et al. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences

Gallbladder and Bile Duct DisordersClinical practice guidelines implementation

Cited by 311

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Nakachi, K., Ikeda, M., Konishi, M., Nomura, S., Katayama, H., Kataoka, T., Todaka, A., Yanagimoto, H., Morinaga, S., Kobayashi, S., et al. (2023) · The Lancet

Cholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct Disorders

Cited by 258